► 4:35 Safety and Efficacy of Asciminib in Third-Line Treatment for CML CML Content Hub @mjmauroMD, of @MSKCancerCenter, discusses #third-line treatment for #CML.
► 1:00:50 Rheumatoid Arthritis: An Overview Rheumatoid Arthritis Content Hub @DuncanFMoore, of @MGHrheumatology, provides an overview of #RheumatoidArthritis.
► 1:14:19 Infectious Diseases and Immunology: TB, Mosquito Pathogens, Antibodies, and More Allergy / Immunology Jeremy Rock, PhD, @leslievosshall, and @c_gaebler of @RockefellerUniv discuss #infectiousdiseases, #diseasespread, and #protection.
► 2:12 Well Tolerated in Preliminary Study: Pembrolizumab + TKIs in CML Patients With Persistent Detectible MRD CML Content Hub @Dr_AmerZeidan, of @Yale, discusses #safety of #pembrolizumab plus #TKIs in #CML.
► 3:06 How the Pharma Industry is Accelerating Innovation COVID-19 Chris Schott, of @JPMorgan, discusses #pharmaceutical #innovations in 2022.
► 02:06 Pancreatic Transplants: A Cure for Diabetes? Diabetes Dr Tambi Jarmi from @MayoClinic recommends early pancreas transplantation to potentially cure diabetes.
► 02:50 Molecular Profiling Provides New Insights to Endometrial Cancer Treatments Ob/Gyn Dr Nicoletta Colombo of the European Institute of Oncology touts the importance of molecular profiling for guiding endometrial cancer treatments.
► 03:11 Managing Atopic Dermatitis Dermatology Dr. Rosmarin @Tufts Medical Center discusses a holistic approach to managing atopic dermatitis.
► 06:14 Advances in the Treatment and Management of Rheumatoid Arthritis Rheumatoid Arthritis Content Hub Drs Daniel Furst and Christina Charles-Schoeman, of @UCLAHealth, discuss #treatment advances in #RheumatoidArthritis.
► 1:53:24 Intel Jam Session: The Future of Surgery, Imaging, and MedEd Medical Students In this second installment of Intel’s Jam Session, a panel of experts discuss the current trends, burgeoning innovations, and future trajectory of digital solutions for clinical practice and…